Optiver Holding’s Relay Therapeutics RLAY Stock Holding History

Optiver Holding’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,228	Closed	-$6.41K	–	2906
2025 Q3	$6.41K	Buy	+1,228	New	+$4.68K	﹤0.01%	1558

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's RLAY Position: Q4 2025 in Review

Optiver Holding sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 1,228 shares — an estimated $6.41K sold.

Optiver Holding first reported a position in RLAY in Q3 2025 and held it in 1 quarter. The position peaked at $6.41K in Q3 2025. 226 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

Optiver Holding reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 1,228 Relay Therapeutics shares in Q4 2025, an estimated $6.41K.
Optiver Holding first reported a position in Relay Therapeutics in Q3 2025 and held it in 1 quarter.
Optiver Holding's Relay Therapeutics position peaked at $6.41K in Q3 2025.
226 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.